Apimeds Pharmaceuticals US, Inc. APUS
Set alert
3.01 USD -0.20 -6.23%
At close · Oct 30
2.88 -0.13 -4.32%
After hours · Oct 30, 5:38 PM ET
2.85 Day range 3.05
1.60 52-week range 38.95
- YTD
- -81.65%
- 1 year
- -85.25%
- Open
- 3.11
- Prev close
- 3.21
- Mkt cap
- 4.54M
- Vol
- 21.48K
- Avg vol
- 3.76M
- EPS
- -36.03
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.85
- High
- 3.05
Financial health
Altman Z-Score
-2.08 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 5
Valuation
P/E -3.0×
FY 2021 5y median -3.0× FY 2025
P/S 0.0×
FY 2021 5y median 0.0× FY 2025
P/B 0.1×
FY 2021 5y median -1.9× FY 2025
P/FCF -2.0×
FY 2021 5y median -3.5× FY 2025
EV/EBITDA -4.2×
FY 2021 5y median -3.2× FY 2025
EV/Sales 0.0×
FY 2021 5y median 0.0× FY 2025
FCF Yield -50.3%
FY 2021 5y median -28.9% FY 2025
Profitability
Gross Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2021 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2021 5y median 0.0% FY 2025
ROE -3.9%
FY 2021 5y median 93.7% FY 2025
ROIC -7.4%
FY 2021 5y median -7.4% FY 2025
ROA -3.7%
FY 2021 5y median -596.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2021 FY 2025
Operating Income -834.2%
FY 2021 FY 2025
EPS (diluted) 50.0%
FY 2021 FY 2025
Free Cash Flow -1124.6%
FY 2021 FY 2025
Financial Health
Current Ratio 1.3×
FY 2021 5y median 1.3× FY 2025
Quick Ratio 1.3×
FY 2021 5y median 1.3× FY 2025
Debt / Equity 0.1×
FY 2021 5y median -0.4× FY 2025
Net Debt / EBITDA -1.1×
FY 2021 5y median -0.5× FY 2025
Interest Coverage -42.1×
FY 2021 5y median -21.9× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31